CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Astra, Daiichi said to be nearing U.K. drug pricing deal for breast cancer drug, Enhertu

RegulatoryEnhertuPositive
AI Analysis

Summary

AstraZeneca and Daiichi Sankyo are reportedly nearing a U.K. drug pricing agreement for Enhertu, their breast cancer treatment.

Importance:3/10
Sentiment:
0.50
pricingU.K.breast cancerregulatorypartnership
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 8, 2026 12:01 PM

Read Original